OpenAlex
PricingAboutJobs
Log inGet started
Author

Wenmin Chen

Institution: Guangzhou University of Chinese Medicine
Observed institution: Guangzhou University of Chinese Medicine
ORCID: 0000-0002-2126-3112
Observed ORCID: 0000-0002-2126-3112
OpenAlex ID: A5025781070
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
2023 · Wenmin Chen, Jietao Lin, et al. · Integrative Cancer Therapies · 7
PDF
Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review
2023 · Jietao Lin, Wenmin Chen, et al. · Frontiers in Pharmacology · 2
PDF
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
2023 · Jietao Lin, Lingling Sun, et al. · Integrative Cancer Therapies · 2
PDF
Works count: 3
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security